On December 2, 2019 CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, reported that the Company will present an overview of the company at the Piper Jaffray 31st Annual Healthcare Conference on Thursday, December 5, 2019 in New York, NY, and meet with investors in 1×1 meetings throughout the day (Press release, Cytosorbents, DEC 2, 2019, View Source [SID1234551848]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Piper Jaffray 31st Annual Healthcare Conference
Where: Lotte New York Palace, 455 Madison Ave, New York, NY
When: Thursday, December 5, 2019 from 11:50AM-12:10PM EST
Webcast: Piper Jaffray 31st Annual Healthcare Conference Webcast Link

A live webcast of the presentation will be available at the above webcast link. An archived replay of the webcast will be available for 90 days following the event.